Copy of Stop big pharma monopolies (5).png

A trade deal with America threatens the very future of our NHS.

“We know from experience that pharmaceutical companies will exploit any opportunity to increase their profits at the cost of people’s health.” - Simon, Just Treatment patient leader — **“We know from experience that pharmaceutical companies will exploit any opportunity to increase their profits at the cost of people’s health.”**
*- Simon, Just Treatment patient leader*

The US government, backed by big pharma, wants to make changes that would vastly increase the price that our health service pays for life saving and life enhancing drugs. This threat remains regardless of who is in the White House.

In the UK, the government has repeated time and again that drug prices are off the table in a trade deal with the US. Yet they have left the door open to changes - for example to intellectual property laws - that could seriously impact drug prices.

Americans pay more than any other country in the world for medicines, and their government wants us to do the same. These sort of price rises would have a catastrophic impact on our health system - and on patients.

The result would be limited access, rationing of drugs and treatments, and a spiralling drugs bill. We would see increasing numbers of patients either having to pay privately for medicines that they desperately need, or go without. Removing the safeguards that limit the NHS drugs bill would inevitably lead to a reduction in the amount of funding available for other NHS services.

Patients and activists around the country are taking action to stop the NHS trade-off. Read some of their stories below, and join the fight to stop a damaging US trade deal before it’s too late.